I. C. Glitza

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results”.

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

Nature Medicine(2023)10.1038/s41591-022-02170-x

N/A

1.9DataRank · unranked

83 citations

Sherise D. Ferguson, Roland L. Bassett, Alexandra P. Foster, Ida John, Tarin Hennegan +32 more

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Science(2018)10.1126/science.aan4236

N/A

1.3DataRank · unranked

4585 citations

C. N. Spencer, Luigi Nezi, Alexandre Reuben, Miles C. Andrews, Tatiana V. Karpinets +89 more

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003277

N/A

0DataRank · unranked

118 citations

David M. Faleck, Anusha Shirwaikar Thomas, Jessica Harris, Deepika Satish, Xuemei Wang +13 more

Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit

Cancer(2021)10.1002/cncr.34004

N/A

0DataRank · unranked

21 citations

Sahira Farooq, Macartney Welborn, Rodabe N. Amaria, Susan Y. Chon, Adi Diab +13 more

CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease

Frontiers in Immunology(2021)10.3389/fimmu.2021.745893

N/A

0DataRank · unranked

9 citations

Anantha Marisetty, Craig Horbinski, James P. Long, Jason T. Huse, I. C. Glitza +8 more

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy

Nature Communications(2022)10.1038/s41467-022-29539-3

N/A

0DataRank · unranked

117 citations

Yanshuo Chu, Mercy Misoi, María E. Suarez‐Almazor, Jean Tayar, Huifang Lu +33 more

Changes in outcomes and factors associated with survival in melanoma patients with brain metastases

Neuro-Oncology(2022)10.1093/neuonc/noac251

N/A

0DataRank · unranked

22 citations

Denái R. Milton, Alicia Bea Davies, Elizabeth Sirmans, Chantal Saberian, Eliza Posada +22 more

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

Pigment Cell & Melanoma Research(2022)10.1111/pcmr.13059

N/A

0DataRank · unranked

16 citations

Maya Dimitrova, Kevin Kleffman, Christopher Alvarez‐Breckenridge, Michael B. Atkins, Adrienne Boire +22 more

“Liquid Gold” - The unTAPped Potential of Cerebrospinal Fluid Analysis?

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0173

N/A

0DataRank · unranked

1 citations

Hussein A. Tawbi, I. C. Glitza

National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities

The Lancet Oncology(2023)10.1016/s1470-2045(23)00297-8

N/A

0DataRank · unranked

39 citations

Minesh P. Mehta, Dee Dee Smart, Patricia S. Steeg, Julie A. Hong, Michael Graham Espey +39 more

Clinical Outcomes of Immune Checkpoint Inhibitor Diabetes Mellitus at a Comprehensive Cancer Center

Immunotherapy(2023)10.2217/imt-2021-0316

N/A

0DataRank · unranked

17 citations

Priyanka Iyer, Conor Best, Victor Lavis, Jeena Varghese, Sireesha Yedururi +7 more

Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care

Pigment Cell & Melanoma Research(2023)10.1111/pcmr.13116

N/A

0DataRank · unranked

8 citations

Adrienne Boire, Priscilla K. Brastianos, Harriet M. Kluger, Eva Hernando‐Monge, Peter Forsyth +6 more

Ventriculoperitoneal shunting with an on–off valve for patients with leptomeningeal metastases and intracranial hypertension

Neuro-Oncology Practice(2023)10.1093/nop/npad056

N/A

0DataRank · unranked

6 citations

Jaime Gasco, I. C. Glitza, Sherise D. Ferguson, Nazarin K Majd, Ian E. McCutcheon +1 more

Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions

Neuro-Oncology(2024)10.1093/neuonc/noae103

N/A

0DataRank · unranked

61 citations

Ugonma Chukwueke, Myung‐Ju Ahn, Ayal A. Aizer, Tejus Bale, Dieta Brandsma +24 more

Rate of response to immune checkpoint inhibitor therapy in patients with conjunctival melanoma

Melanoma Research(2024)10.1097/cmr.0000000000001016

N/A

0DataRank · unranked

7 citations

Tyler Ogden, Matthew Nichols, Tracy Lu, J. Matthew Debnam, Florentia Dimitriou +3 more

RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study

Molecular Cancer(2024)10.1186/s12943-024-01982-4

N/A

0DataRank · unranked

2 citations

Jason Roszik, Jibran Ahmed, Carmelia Maria Noia Barretto, Mirella Nardo, Erick Campbell +9 more

Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier

Nutrients(2025)10.3390/nu18010040

N/A

0DataRank · unranked

1 citations

Satabdi Saha, Nazli Dizman, Michelle Rohlfs, Elizabeth Sirmans, J. M. Gardner +17 more